MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study

Table 1

Clinical features of the patients under study.

	Controls ()	MPM ()	ASB ()
Gender	12 M/3 F	24 M/8 F	8 M/6 F
Age (years)	69.9; (SD: 7.0)	72.3; (SD: 15.6)	75.9; (SD: 9.9)
Smoking history	5 NS; 7 S; 3 EXS	12 NS; 20 S	8 NS; 4 S; 2 EXS
Diagnosis	8 nodules; 3 bronchiectasis; 4 other†	26 epithelioid; 6 biphasic
Stage		2 I; 9 II; 15 III; 6 IV

NS: nonsmokers; EXS: ex-smokers; S: smokers; SD: standard deviation; †Inflammatory disease (n. 2), aspiration pneumonia (n. 1), and rhino-bronchial syndrome (n. 1).